Anoxia at birth induced hyperresponsiveness to amphetamine and stress in postpubertal rats.
Several evidences suggest that transient global anoxia after Caeraean section birth in rats produces behavioral changes related to dopaminergic transmission. However, all of the reports tested the behavioral changes in adult rats. Here we investigated the role of perinatal anoxia on behavioral paradigms related to dopamine (DA) such as novel environment, saline injection, D-amphetamine, apomorphine and stress-induced changes in locomotor activity at prepubertal and postpubertal ages. All these dimensions of behavior can be affected in schizophrenia. Caesarean section birth with or without an additional period of anoxia was performed in Sprague-Dawley rats and their behaviors were studied at P35 and P56, respectively. In addition, a third group of animals born vaginally served as control. No significant differences in saline injection and D-amphetamine-induced locomotion were observed when the three groups of rats at P35 were compared. However, stress-induced locomotor activity was significantly increased in the Caesarean birth plus anoxia at P35, while after puberty (at P56), saline injection, D-amphetamine and stress-induced locomotion were significantly enhanced in the Caesarean birth plus anoxia compared to its control groups. The data suggests that anoxia at birth mediates differently the functional development and maturation of DA behaviors in adult rats.
Juárez
Ismael
I
Laboratorio de Neuropsiquiatría, Instituto de Fisiología, Universidad Autónoma de Puebla, 14 Sur 6301, CP 72570, Puebla, Mexico.
Silva-Gómez
Adriana B
AB
Peralta
Fernando
F
Flores
Gonzalo
G
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000254:growth & development / Q000378:metabolism / Q000503:physiopathology*; D002585:Cesarean Section / Q000009:adverse effects; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005311:Fetal Hypoxia / Q000150:complications / Q000503:physiopathology*; D006801:Humans; D002534:Hypoxia, Brain / Q000150:complications / Q000503:physiopathology; D007231:Infant, Newborn; D008297:Male; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012559:Schizophrenia / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D012741:Sexual Maturation / Q000502:physiology; D013312:Stress, Physiological / Q000378:metabolism / Q000503:physiopathology*
D015259:Dopamine Agents; D000661:Amphetamine; D004298:Dopamine